Boston Scientific Beefs Up Electrophysiology, Structural Heart Portfolio With $1.75B Baylis DealBenzinga • 10/06/21
Boston Scientific Highlights Trial Data For EkoSonic System For Pulmonary EmbolismBenzinga • 10/06/21
Positive Late-breaking Clinical Trial Data for the EkoSonic™ Endovascular System Presented at VIVA21PRNewsWire • 10/05/21
Boston Scientific Announces Positive Late-Breaking Clinical Trial Data for the Ranger™ Drug-Coated BalloonPRNewsWire • 10/05/21
Boston Scientific Announces Conference Call Discussing Third Quarter 2021 ResultsPRNewsWire • 10/04/21
Boston Scientific: A Best Price-Positioned Medical Equipment Stock, As Seen By Market-MakersSeeking Alpha • 09/23/21
Boston Scientific Posts Colorectal Cancer Survival Data For Tumor-Targeting MicrobeadsBenzinga • 09/20/21
Late-Breaking Data Demonstrate Improved Progression-Free Survival in Patients with Metastatic Colorectal Cancer After Treatment with Boston Scientific TheraSphere™ Y-90 Glass MicrospheresPRNewsWire • 09/20/21
Boston Scientific Closes Acquisition Of Lumenis LTD. Surgical Business From Baring Private Equity AsiaPRNewsWire • 09/01/21
Why Is Boston Scientific (BSX) Down 1.4% Since Last Earnings Report?Zacks Investment Research • 08/26/21
Post Market Studies Reinforce Unfavorable Risk-Benefit Profile For Boston Scientific's Vaginal MeshBenzinga • 08/17/21
Boston Scientific Receives FDA Clearance for EXALT™ Model B Single-Use BronchoscopePRNewsWire • 08/10/21